Skip Navigation
NIH

Talking Glossary of Genetic Terms

Listen to Definition

Lawrence C. Brody, Ph.D. defines Ancestry-informative Markers

Ancestry-informative Markers

Ancestry-informative markers are sets of polymorphisms for a particular DNA sequence that appear in substantially different frequencies between populations from different geographical regions of the world. Ancestry-informative markers can be used to estimate the geographical origins of the ancestors of an individual typically by continent of origin (Africa, Asia, or Europe).

How to cite this term How to cite this term for research papers


A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Ancestry-informative Markers

Ancestry-informative markers are sets of polymorphisms for a particular DNA sequence that appear in substantially different frequencies between populations from different geographical regions of the world. Ancestry-informative markers can be used to estimate the geographical origins of the ancestors of an individual typically by continent of origin (Africa, Asia, or Europe).

Narration Transcription

Ancestry informative markers refers to locations in the genome that have varied sequences at that location and the relative abundance of those markers differs based on the continent from which individuals can trace their ancestry. So by using a series of these ancestry informative markers, sometimes 20 or 30 or more, and genotyping an individual you can determine from the frequency of those markers where their great, great, great, great ancestors may have come from. These are generally resolved to the three major continents: Africa, Asia, and Europe. Ancestry informative markers are used in epidemiological studies to see whether or not people have the same background, and sometimes they are used in forensic studies as well.


Doctor Profile

Lawrence C. Brody, Ph.D.

Lawrence C. Brody, Ph.D.

Occupation
Chief & Senior Investigator, Genome Technology Branch; Head, Molecular Pathogenesis Section

Biography
Dr. Brody investigates the genetics of breast cancer and neural tube defects. As chief of the NHGRI Genome Technology Branch's Molecular Pathogenesis section, he is interested in studying genetic mutations that lead to perturbations in normal metabolic pathways and cause disorders such as cancer and birth defects. His laboratory investigates mutations in two breast cancer-linked genes, breast cancer gene 1 (BRCA1) and breast cancer gene 2 (BRCA2). Dr. Brody's laboratory was among the first to report that women carrying BRCA1 or BRCA2 mutations have a higher risk of developing both breast and ovarian cancer than women without such mutations.

How to cite this termHow to cite this term for research papers

About the Talking Glossary
all Top